Diadenosine-5 ,5ٟ-P 1 ,P 4 -tetraphosphate (Ap4A) and its analog P 2 ,P 3 -monochloromethylene diadenosine-5 ,5ٟ-P 1 ,P 4 -tetraphosphate (AppCHClppA) are competitive inhibitors of adenosine diphosphate-induced platelet aggregation, which plays a central role in arterial thrombosis and plaque formation. In this study, we evaluate the imaging capabilities of positron-emission tomography (PET) with P 2 ,P 3 -[ 18 F]monofluoromethylene diadenosine-5 ,5ٟ-P 1 ,P 4 -tetraphosphate ([ 18 F]AppCHFppA) to detect atherosclerotic lesions in male New Zealand White rabbits. Three to six months after balloon injury to the aorta, the rabbits were injected with O ur previous findings with 99m Tc-conjugated diadenosine-5Ј,5ٞ-P 1 ,P 4 -tetraphosphate (Ap 4 A) and P 2 ,P 3 -monochloromethylene diadenosine-5Ј,5ٞ-P 1 ,P 4 -tetraphosphate (AppCHClppA) in a rabbit model indicated rapid, high accumulation of both diadenosine tetraphosphate analogs in the atherosclerotic abdominal aorta and demonstrated up-regulation of purine receptors in experimental atherosclerotic lesions, suggesting the potential for using such labeled analogs for noninvasive detection of plaque formation (1, 2). The atherogenic process involves sequestration of partially oxidized lipids in the vessel wall (3, 4), leading to endothelial injury that promotes adherence of mononuclear cells and platelets and contributes to phenotypic transformation of medial smooth muscle cells (SMCs) from adult to embryonic forms. The transformed muscle cells proliferate and migrate to the intima in parallel with accumulation of lipids by monocytes, causing the formation of foam cells. Other processes of plaque formation, involving T lymphocytes, platelets, cytokine release, and growth factors, enhance migration and proliferation of SMCs (3-7). Vulnerable plaque formation is associated with increased monocyte͞macrophage representation and arterial wall cap thinning. Plaque disruption is the major event for inducing thrombosis and acute coronary syndromes (8).Evidence indicates an important role for adenosine nucleotides in the development of atherosclerotic plaque inflammation. Extracellular adenosine nucleotides are released from a variety of cells and regulate many physiologic activities by interaction with P2 receptors or adenosine nucleotide receptors (9-12). The development of atherosclerosis is closely associated with upregulation of the extracellular purinergic receptor P2Y 2 R, whose activation in vascular endothelial cells induces expression of vascular cell adhesion molecule 1 (VCAM-1) and adherence of monocytes, as well as the release of proinflammatory chemokines (13).Molecular imaging probes and techniques based on intravascular MRI, computed tomography (CT), ultrasound, and optical coherence tomography have been proposed for accurate identification of atherosclerotic plaque, plaque formation, and vul-